cemiplimab
sanofi,regeneron
['libtayo', 'improve ', 'regeneron']
 's oncology strategy is to improve checkpoint inhibitor treatments with combination therapies centered around libtayo according to a pipeline overview presented to investors monday morning. #regeneron #biotech #lifescience #biospace 
Your source for biopharma news and jobs